Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.

MLA

Bogan, Carley M., et al. “Evaluation of Intravitreal Topotecan Dose Levels, Toxicity and Efficacy for Retinoblastoma Vitreous Seeds: A Preclinical and Clinical Study.” British Journal of Ophthalmology, vol. 106, no. 2, Feb. 2022, pp. 288–96. EBSCOhost, https://doi.org/10.1136/bjophthalmol-2020-318529.

APA

Bogan, C. M., Kaczmarek, J. V., Pierce, J. M., Chen, S., Boyd, K. L., Calcutt, M. W., Bridges, T. M., Lindsley, C. W., Nadelmann, J. B., Liao, A., Hsieh, T., Abramson, D. H., Francis, J. H., Friedman, D. L., Richmond, A., & Daniels, A. B. (2022). Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. British Journal of Ophthalmology, 106(2), 288–296. https://doi.org/10.1136/bjophthalmol-2020-318529

Chicago

Bogan, Carley M., Jessica V. Kaczmarek, Janene M. Pierce, Sheau-chiann Chen, Kelli L. Boyd, Marion W. Calcutt, Thomas M. Bridges, et al. 2022. “Evaluation of Intravitreal Topotecan Dose Levels, Toxicity and Efficacy for Retinoblastoma Vitreous Seeds: A Preclinical and Clinical Study.” British Journal of Ophthalmology 106 (2): 288–96. doi:10.1136/bjophthalmol-2020-318529.